Article info
PDFLung cancer
Original research
Genetically raised serum bilirubin levels and lung cancer: a cohort study and Mendelian randomisation using UK Biobank
- Correspondence to Dr Laura Jane Horsfall, Department of Primary Care & Population Health, UCL, London, London NW3 2PF, UK; laura.horsfall{at}ucl.ac.uk
Citation
Genetically raised serum bilirubin levels and lung cancer: a cohort study and Mendelian randomisation using UK Biobank
Publication history
- Received March 4, 2020
- Revised May 26, 2020
- Accepted June 12, 2020
- First published August 27, 2020.
Online issue publication
September 01, 2022
Article Versions
- Previous version (15 December 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.